Author

U. Klingmueller

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:differential expression· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

A. Dugourd· 1 shared A. Goncalves· 1 shared A. K. Miller· 1 shared A. Kopp-Schneider· 1 shared A. Teleman· 1 shared B. Helm· 1 shared C. Brandstaedter· 1 shared C. Hopf· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Dugourd

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer

S. Richtmann, S. Marwitz, T. Muley, H. Koistinnen, P. Christopoulos, M. Thomas, D. N. Kazdal, M. Allgaeuer, H. Winter, T. Goldmann, M. Meister, U. Klingmueller, M. A. Schneider

This paper identifies glycodelin as a sex-specific factor influencing immunotherapy resistance in NSCLC, showing it impairs survival in female patients and interacts with immune cells.

bioRxiv · Mar 2, 2023Cancer Biology

Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs

J. Samarin, P. Fabrowski, R. Kurilov, H. Nuskova, J. Hummel-Eisenbeiss, H. Pink, N. Li, V. Weru, H. Alborzinia, U. Yildiz, L. Grob, M. Taubert, M. Czech, M. Morgen, C. Brandstaedter, , N. Gunkel

The paper identifies antioxidant-capacity biomarkers (ACBs) that predict susceptibility to ROS-inducing drugs in lung cancer cells, showing that low ACB expression correlates with nitric oxide levels, not ROS levels.

bioRxiv · Jan 17, 2023Cancer Biology

Pre-analytical processing of plasma and serum samples for combined proteome and metabolome analysis

H. M. Gegner, T. Naake, A. Dugourd, T. Mueller, F. Czernilofsky, G. Kliewer, E. Jaeger, B. Helm, N. Kunze-Rohrbach, U. Klingmueller, C. Hopf, C. Mueller-Tidow, S. Dietrich, J. Saez-Rodriguez, W. Huber, , J. Krijgsveld

This study evaluates pre-analytical factors affecting plasma and serum proteome and metabolome stability, recommending standardized protocols for clinical use.

bioRxiv · Apr 26, 2022Biochemistry